"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

ERIS Lifesciences Ltd
Industry : Pharmaceuticals - Indian - Formulations	Chairman : Amit Indubhushan Bakshi
Home : Indian Private	Book Value: 184.651184
BSE Code : 540596	Market Cap: 23474.97
NSE Code : ERIS	P / E : 303.45

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	395.71	390.00	428.75	449.17
Other Income	16.75	7.79	5.81	5.16
Total Income	421.52	407.52	442.37	461.85
Total Expenditure	283.80	300.16	293.93	333.31
Operating Profit	137.72	107.36	148.44	128.54
Interest	53.16	54.65	56.26	56.17
Gross Profit	84.56	52.71	92.18	72.37
Depreciation	43.38	46.68	46.16	45.55
Tax	8.51	0.00	8.78	4.69
Deferred Tax	2.20	4.25	9.14	5.09
Reported Profit After Tax	30.47	1.78	28.10	17.04

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView